1. Home
  2. EPM vs VRCA Comparison

EPM vs VRCA Comparison

Compare EPM & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolution Petroleum Corporation Inc.

EPM

Evolution Petroleum Corporation Inc.

HOLD

Current Price

$4.16

Market Cap

165.9M

Sector

Energy

ML Signal

HOLD

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$5.73

Market Cap

137.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPM
VRCA
Founded
2003
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
165.9M
137.3M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
EPM
VRCA
Price
$4.16
$5.73
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$4.83
$17.00
AVG Volume (30 Days)
324.3K
35.3K
Earning Date
05-05-2026
05-11-2026
Dividend Yield
10.08%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,229,621.00
$35,577,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$94.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
370.22
52 Week Low
$3.19
$0.52
52 Week High
$5.70
$9.82

Technical Indicators

Market Signals
Indicator
EPM
VRCA
Relative Strength Index (RSI) 43.19 44.47
Support Level $4.13 $5.27
Resistance Level $4.63 $6.48
Average True Range (ATR) 0.14 0.49
MACD -0.01 -0.01
Stochastic Oscillator 26.92 19.17

Price Performance

Historical Comparison
EPM
VRCA

About EPM Evolution Petroleum Corporation Inc.

Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: